Glen Harbor Capital Management’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $186K | Buy |
16,116
+3,706
| +30% | +$42.8K | ﹤0.01% | 1040 |
|
|
2019
Q2 | $124K | Buy |
12,410
+3,026
| +32% | +$30.2K | ﹤0.01% | 1135 |
|
|
2019
Q1 | $121K | Hold |
9,384
| – | – | ﹤0.01% | 1114 |
|
|
2018
Q4 | $143K | Hold |
9,384
| – | – | ﹤0.01% | 1039 |
|
|
2018
Q3 | $188K | Hold |
9,384
| – | – | ﹤0.01% | 1078 |
|
|
2018
Q2 | $183K | Hold |
9,384
| – | – | ﹤0.01% | 999 |
|
|
2018
Q1 | $189K | Buy |
9,384
+1,224
| +15% | +$24.7K | ﹤0.01% | 989 |
|
|
2017
Q4 | $108K | Buy |
8,160
+1,836
| +29% | +$24.3K | ﹤0.01% | 1140 |
|
|
2017
Q3 | $117K | Buy |
6,324
+1,734
| +38% | +$32.1K | ﹤0.01% | 1082 |
|
|
2017
Q2 | $84K | Buy |
4,590
+2,380
| +108% | +$43.6K | ﹤0.01% | 1124 |
|
|
2017
Q1 | $50K | Buy |
2,210
+102
| +5% | +$2.31K | ﹤0.01% | 1126 |
|
|
2016
Q4 | $73K | Buy |
+2,108
| New | +$73K | ﹤0.01% | 1001 |
|